Do we need marker gene studies in humans to improve clinical AAV gene therapy?
Crossref DOI link: https://doi.org/10.1038/gt.2016.84
Published Online: 2017-01-05
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weber, T http://orcid.org/0000-0002-0494-0484
Text and Data Mining valid from 2017-01-05
Version of Record valid from 2017-01-05
Article History
Received: 19 September 2016
Revised: 22 November 2016
Accepted: 24 November 2016
First Online: 5 January 2017
Competing interests
: The author declares no conflict of interest.